Valneva SE (VALN) Equity Income (2021 - 2025)
Valneva SE (VALN) reported Equity Income of -$58.2 million for Q4 2025, down 47.6% on a YoY basis from -$111.1 million in Q4 2024, and down 12.13% sequentially from -$51.9 million in Q3 2025.
Valneva SE (VALN) Equity Income (2021 - 2025) Analysis & Trends
Valneva SE (VALN) has 3 years of Equity Income data on file, last reported at -$58.2 million in Q4 2025.
- For the quarter ending Q4 2025, Equity Income fell 47.6% year-over-year to -$58.2 million; the trailing twelve-month figure through Dec 2025 stood at -$159.8 million (down 3.91% YoY), and the FY2025 full-year result was -$134.1 million, down 915.54% from the prior year.
- Equity Income slipped to -$58.2 million in Q4 2025, from -$51.9 million in the prior quarter.
- In the past five years, Equity Income ranged from a high of -$10.2 million in Q3 2024 to a low of -$70.7 million in Q2 2021.
- A 3-year average of -$44.0 million and a median of -$45.7 million in 2025 frame the typical range for Equity Income.
- Peak annual rise in Equity Income reached 47.6% in 2025, while the deepest fall reached 408.21% in 2025.
- Tracing VALN's Equity Income over 3 years: stood at -$70.7 million in 2021, then jumped by 44.22% to -$39.4 million in 2024, then sank by 47.6% to -$58.2 million in 2025.
- Business Quant data shows VALN's Equity Income at -$58.2 million in Q4 2025, -$51.9 million in Q3 2025, and -$39.4 million in Q4 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | - |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Valneva SE | 811.46 Mn | 688.23 Mn | 5.08 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | -58.20 Mn |
| Sep 30, 2025 | -51.91 Mn |
| Dec 31, 2024 | -39.43 Mn |
| Sep 30, 2024 | -10.21 Mn |
| Jun 30, 2021 | -70.69 Mn |
| Mar 31, 2021 | -33.41 Mn |